The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Tumour mutational burden (TMB) predicts immunotherapy outcome in non-small cell lung cancer (NSCLC), consistent with immune recognition of tumour neoantigens. However, persistent antigen exposure is detrimental for T cell function. How TMB affects CD4 and CD8 T cell differentiation in untreated tumours and whether this affects patient outcomes is unknown. Here, we paired high-dimensional flow cytometry, exome, single-cell and bulk RNA sequencing from patients with resected, untreated NSCLC to examine these relationships. TMB was associated with compartment-wide T cell differentiation skewing, characterized by loss of TCF7-expressing progenitor-like CD4 T cells, and an increased abundance of dysfunctional CD8 and CD4 T cell subsets with strong phenotypic and transcriptional similarity to neoantigen-reactive CD8 T cells. A gene signature of redistribution from progenitor-like to dysfunctional states was associated with poor survival in lung and other cancer cohorts. Single-cell characterization of these populations informs potential strategies for therapeutic manipulation in NSCLC. Ghorani et al. use a multiomics approach to characterize the effect of tumour mutational burden on the differentiation of CD4 and CD8 T cell subpopulations in non-small cell lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationCharoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
xCell: digitally portraying the tissue cellular heterogeneity landscape
Aran, D., Hu, Z., & Butte, A. J. (2017) · Genome Biology · doi:10.1186/s13059-017-1349-1 · Cited by 4,397
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065
Self-citationGenomic correlates of response to CTLA-4 blockade in metastatic melanoma
Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Sahin, U., Derhovanessian, E., Miller, M., Kloke, B.-P., Simon, P., Löwer, M., Bukur, V., Tadmor, A. D., Luxemburger, U., Schrörs, B., et al. (2017) · Nature · doi:10.1038/nature23003 · Cited by 2,488
Tracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349
Self-citation
Cited by
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Litchfield, K., Reading, J. L., Puttick, C., Thakkar, K., Abbosh, C., Bentham, R., Watkins, T. B. K., Rosenthal, R., Biswas, D., Rowan, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.002 · Cited by 893
“(2018) and suggests that neoantigen reactivity is coupled to a CXCL13-secreting ‘‘exhausted’’ phenotype, possibly induced by chronic TCR signaling, as we have recently proposed occurs in NSCLC (Ghorani et al., 2020).”
InfluentialSelf-citationPan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Chu, Y., Dai, E., Li, Y., Han, G., Pei, G., Ingram, D. R., Thakkar, K., Qin, J.-J., Dang, M., Le, X., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02371-y · Cited by 478
Self-citationMolecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers
Lowery, F. J., Krishna, S., Yossef, R., Parikh, N. B., Chatani, P. D., Zacharakis, N., Parkhurst, M. R., Levin, N., Sindiri, S., Sachs, A., et al. (2022) · Science · doi:10.1126/science.abl5447 · Cited by 447
Krishna, C., DiNatale, R. G., Kuo, F., Srivastava, R. M., Vuong, L., Chowell, D., Gupta, S., Vanderbilt, C., Purohit, T. A., Liu, M., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.007 · Cited by 432
Tumour burden and efficacy of immune-checkpoint inhibitors
Dall’Olio, F. G., Marabelle, A., Caramella, C., Garcia, C., Aldea, M., Chaput, N., Robert, C., & Besse, B. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00564-3 · Cited by 350
Metadata
- Authors
- Ghorani, E., Reading, J. L., Henry, J. Y., Massy, M. R. D., Rosenthal, R., Turati, V., Joshi, K., Furness, A. J. S., Ben Aissa, A., Saini, S. K., Ramskov, S., Georgiou, A., Sunderland, M. W., Wong, Y. N. S., Mucha, M. V. D., Day, W., Galvez-Cancino, F., Becker, P. D., Uddin, I., Oakes, T., Ismail, M., Ronel, T., Woolston, A., Jamal-Hanjani, M., Veeriah, S., Birkbak, N. J., Wilson, G. A., Litchfield, K., Conde, L., Guerra-Assunção, J. A., Blighe, K., Biswas, D., Salgado, R., Lund, T., Bakir, M. A., Moore, D. A., Hiley, C. T., Loi, S., Sun, Y., Yuan, Y., AbdulJabbar, K., Turajilic, S., Herrero, J., Enver, T., Hadrup, S. R., Hackshaw, A., Peggs, K. S., McGranahan, N., Chain, B., TRACERx Consortium, Swanton, C., Jamal-Hanjani, M., Peggs, K. S., Georgiou, A., Sunderland, M. W., Reading, J. L., Quezada, S. A., Ghorani, E., Massy, M. R. D., Moore, D. A., Hackshaw, A., McGranahan, N., Rosenthal, R., Veeriah, S., Biswas, D., Hiley, C. T., Chain, B., Wilson, G. A., Birkbak, N. J., Bakir, M. A., Litchfield, K., Herrero, J., Salgado, R., Ngai, Y., Sharp, A., Rodrigues, C., Pressey, O., Smith, S., Gower, N., Dhanda, H., Lawrence, D., Hayward, M., Panagiotopoulos, N., George, R., Patrini, D., Falzon, M., Borg, E., Khiroya, R., Ahmed, A., Taylor, M., Choudhary, J., Shaw, P., Janes, S. M., Forster, M., Ahmad, T., Lee, S. M., Carnell, D., Mendes, R., George, J., Navani, N., Scarci, M., Bertoja, E., Stephens, R. C. M., Hoogenboom, E. M., Holding, J. W., Bandula, S., Watkins, T. B. K., Escudero, M., Stewart, A., Rowan, A., Goldman, J., Van Loo, P., Stone, R. K., Denner, T., Nye, E., Ward, S., Lim, E. L., Boeing, S., Greco, M., Nicod, J., Puttick, C., Enfield, K., Colliver, E., Campbell, B., Abbosh, C., Wu, Y., Skrzypski, M., Hynds, R. E., Marafioti, T., Hartley, J. A., Gorman, P., Lowe, H. L., Ensell, L., Spanswick, V., Karamani, A., Razaq, M., Beck, S., Huebner, A., Dietzen, M., Naceur-Lombardelli, C., Akther, M. A., Zhai, H., Kannu, N., Manzano, E., Bola, S. K., Hoxha, E., Hatipoglu, E., Ogwuru, S., Price, G., Dubois-Marshall, S., Kerr, K., Palmer, S., Cheyne, H., Miller, J., Buchan, K., Chetty, M., Khalil, M., Ezhil, V., Prakash, V., Anand, G., Khan, S., Lau, K., Sheaff, M., Schmid, P., Lim, L., Conibear, J., Schwarz, R., Tugwood, J., Pierce, J., Dive, C., Brady, G., Rothwell, D. G., Chemi, F., Kilgour, E., Blackhall, F., Priest, L., Krebs, M. G., Crosbie, P., Le Quesne, J., Riley, J., Primrose, L., Martinson, L., Carey, N., Shaw, J. A., Fennell, D., Nakas, A., Rathinam, S., Nelson, L., Ryanna, K., Tuffail, M., Bajaj, A., Morgan, F., Kornaszewska, M., Attanoos, R., Adams, H., Davies, H., Carter, M., Lindsay, C. R., Gomes, F., Szallasi, Z., Csabai, I., Diossy, M., Aerts, H., Kirk, A., Asif, M., Butler, J., Bilanca, R., Kostoulas, N., MacKenzie, M., Wilcox, M., Busacca, S., Dawson, A., Lovett, M. R., Shackcloth, M., Feeney, S., Asante-Siaw, J., Gosney, J., Leek, A., Totten, N., Hodgkinson, J. D., Waddington, R., Rogan, J., Moore, K., Monteiro, W., Marshall, H., Blyth, K. G., Dick, C., Kidd, A., Lim, E., Sousa, P. D., Jordan, S., Rice, A., Raubenheimer, H., Bhayani, H., Hamilton, M., Ambrose, L., Devaraj, A., Chavan, H., Begum, S., Mani, A., Kaniu, D., Malima, M., Booth, S., Nicholson, A. G., Fernandes, N., Wallen, J. E., Shah, P., Danson, S., Bury, J., Edwards, J., Hill, J., Matthews, S., Kitsanta, Y., Rao, J., Tenconi, S., Socci, L., Suvarna, K., Kibutu, F., Fisher, P., Young, R., Barker, J., Taylor, F., Lloyd, K., Light, T., Horey, T., Papadatos-Pastos, D., Russell, P., Lock, S., Gilbert, K., Naidu, B., Langman, G., Robinson, A., Bancroft, H., Kerr, A., Kadiri, S., Ferris, C., Middleton, G., Djearaman, M., Patel, A., Ottensmeier, C., Chee, S., Johnson, B., Alzetani, A., Shaw, E., Lester, J., Summers, Y., Califano, R., Taylor, P., Shah, R., Krysiak, P., Rammohan, K., Fontaine, E., Booton, R., Evison, M., Moss, S., Novasio, J., Joseph, L., Bishop, P., Chaturvedi, A., Doran, H., Granato, F., Joshi, V., Smith, E., Montero, A., Swanton, C., & Quezada, S. A.
- Venue
- Nature Cancer
- Published
- 2020-05-22
- Volume
- 1
- Issue
- 5
- Pages
- 546-561
- ISSN
- 2662-1347 (ISSN-L)
- OpenAlex
- W3026574591
- Cited by
- 96
- References
- 34
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The T cell differentiation landscape is shaped by tumour mutations in lung cancer. https://app.cochat.ai/papers/10.1038/s43018-020-0066-y
- The paper
- Ghorani, E., Reading, J. L., Henry, J. Y., Massy, M. R. D., Rosenthal, R., Turati, V., Joshi, K., Furness, A. J. S., Ben Aissa, A., Saini, S. K., Ramskov, S., Georgiou, A., Sunderland, M. W., Wong, Y. N. S., Mucha, M. V. D., Day, W., Galvez-Cancino, F., Becker, P. D., Uddin, I., . . . Quezada, S. A. (2020). The T cell differentiation landscape is shaped by tumour mutations in lung cancer. Nature Cancer. https://doi.org/10.1038/s43018-020-0066-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.